The product is being recalled because the infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL single-dose bag, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 m
Dr. Prabhavathi brings over 14 years of unparalleled experience in pediatrics and a specialized focus on neurodevelopmental disorders
Olanzapine is indicated for the acute and maintenance treatment of schizophrenia and related psychotic disorders
According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD 355 million annually
The company will also share results in two additional posters for deuruxolitinib
The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
Fischer MVL envisages to offer a diverse portfolio of diagnostic solutions
Studies will Investigate Antidepressant Properties of Ketamir to Position for Initial IND Application in 2024
This integrated care offering is a step forward in our vision of providing an effective continuum of care for patients
WINLEVI works differently from any other topical acne treatment
Subscribe To Our Newsletter & Stay Updated
